Business Context and Reporting Period
This Form 8-K Current Report was filed by VisionWave Holdings, Inc. on September 16, 2026. The filing details the execution of a 1-for-20 reverse stock split of the Company's common stock, approved by stockholders at the Annual Meeting on September 1, 2026. The amendment to the Certificate of Incorporation was filed with the Delaware Secretary of State on September 16, 2026, with an effective time set for 12:01 a.m. Eastern Time on September 22, 2026.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Share Count Reduction: The reverse stock split reduces issued and outstanding shares from approximately 47.5 million to approximately 2.4 million.
- Fractional Share Treatment: No fractional shares will be issued; any fractional entitlements are rounded up to the next whole share. No cash is paid in lieu of fractional shares.
- Warrant Adjustments: Publicly traded Redeemable Warrants (VWAVW) will be adjusted such that each warrant is exercisable for 1/20th of a share, with the exercise price proportionately adjusted to $230.00 per whole share.
- Trading Symbol and CUSIP: The stock will continue to trade under the symbol "VWAV" on The Nasdaq Global Market but will utilize a new CUSIP number (927950204) effective September 22, 2026.
- Authorized Shares: The total authorized share count remains 160,000,000 (150,000,000 common, 10,000,000 preferred), significantly increasing the pool of unissued shares available for future issuance.
Guidance, Outlook, and Risks
Management Commentary: The primary objective of the reverse stock split is to increase the per-share trading price to maintain compliance with Nasdaq Listing Rule 5450(a)(1), which requires a minimum bid price of $1.00.
Risks and Contingencies:
- There is no assurance that the split will result in a sustained increase in the share price or that the Company will satisfy Nasdaq's continued listing requirements.
- Future issuances of the increased number of authorized but unissued shares could be dilutive to existing stockholders.
- Operational risks include potential delays in processing the split by Nasdaq, the transfer agent, or The Depository Trust Company.
- Reduced liquidity of the common stock is cited as a potential risk.
Investor Verification Checklist
- Verify the effective date of the split (September 22, 2026) and the new CUSIP number (927950204) with your broker.
- Confirm the adjusted exercise price of any held Redeemable Warrants ($230.00) and the new share entitlement (1/20th share per warrant).
- Review the Company's most recent Form 10-K and 10-Q for underlying financial health, as this 8-K does not provide financial performance data.
- Monitor the stock price post-split to determine if the $1.00 minimum bid price requirement is met.